Translational Genomics

CRISPR Off-Target Effects Mitigation

Development of computational and molecular strategies to predict, prevent, and minimize unintended genomic modifications during CRISPR-Cas9 gene editing applications.

RESEARCH GAP FRONTIERS

Liquid Biopsy Circulating Tumor DNA

Clinical translation of non-invasive ctDNA detection technologies for early cancer detection, minimal residual disease monitoring, and treatment response assessment.

RESEARCH GAP FRONTIERS

Polygenic Risk Score Implementation

Translation of multi-locus genetic risk prediction models into clinical practice for disease stratification and personalized preventive medicine strategies.

RESEARCH GAP FRONTIERS

Long-Read Sequencing Clinical Applications

Integration of third-generation sequencing platforms for structural variant detection and complex disease diagnosis in clinical genomics workflows.

RESEARCH GAP FRONTIERS

Gene Therapy Delivery System Optimization

Engineering and validation of viral and non-viral vectors for efficient, targeted, and safe therapeutic gene delivery to diseased tissues.

RESEARCH GAP FRONTIERS

Single-Cell RNA Sequencing Biomarkers

Discovery and validation of cell-type-specific transcriptomic signatures as prognostic and predictive biomarkers for disease heterogeneity and treatment response.

RESEARCH GAP FRONTIERS

Epigenetic Aging Clock Development

Construction and clinical validation of DNA methylation-based biological age predictors for aging-related disease risk stratification and intervention monitoring.

RESEARCH GAP FRONTIERS

Somatic Mutation Burden Quantification

Standardization of tumor mutational load assessment methodologies for immunotherapy response prediction and clinical decision-making in oncology.

RESEARCH GAP FRONTIERS

Mitochondrial DNA Disease Therapeutics

Development of targeted interventions for primary mitochondrial disorders through mitochondrial genome editing and heteroplasmy modulation strategies.

RNA Therapeutics Target Discovery

Genome-wide identification and validation of disease-relevant RNA targets for antisense oligonucleotide and small interfering RNA therapeutic development.

Precision Oncology Tumor Profiling

Comprehensive genomic and transcriptomic characterization of individual tumors to guide targeted therapy selection and predict treatment resistance mechanisms.

Variant of Uncertain Significance Classification

Development of integrated computational and functional approaches to reclassify ambiguous genetic variants and improve clinical interpretation accuracy.

High-Throughput CRISPR Screen Translation

Conversion of genome-wide CRISPR knockout and activation screening results into validated drug targets and therapeutic intervention opportunities.

Prenatal Cell-Free DNA Screening

Clinical implementation and optimization of non-invasive prenatal testing for chromosomal and genomic abnormality detection in pregnancy.

Pharmacogenomics Clinical Decision Support

Integration of pharmacogenetic knowledge into electronic health record systems to guide personalized medication selection and dosing recommendations.

Immune Repertoire Sequencing Analysis

Characterization of T-cell and B-cell receptor diversity as biomarkers for immunotherapy response, infection detection, and clonal expansion monitoring.

Splicing Variant Functional Prediction

Machine learning-based prediction and experimental validation of splice-altering variants to assess disease causality and therapeutic targeting potential.

Patient-Derived Xenograft Genomics

Genomic profiling and molecular characterization of patient-derived tumor models to predict drug sensitivity and guide personalized treatment strategies.

Neoantigen Personalized Cancer Vaccines

Computational identification and immunogenicity validation of patient-specific tumor neoantigens for personalized immunotherapy vaccine development.

Microbiome Genomics Disease Association

Metagenomic characterization of host-microbiome interactions and pathogenic microorganisms for disease diagnosis and therapeutic intervention design.

Structural Variant Disease Mechanism Elucidation

Functional characterization of large genomic rearrangements to determine pathogenic mechanisms and guide targeted therapeutic development.

Artificial Intelligence Genomic Data Integration

Development of deep learning and machine learning approaches to integrate multi-omics data for phenotype prediction and disease stratification.

Non-Coding RNA Therapeutic Development

Identification and clinical translation of disease-relevant long non-coding RNAs and regulatory RNAs as therapeutic targets and biomarkers.

Base Editing Therapeutic Application

Optimization and clinical translation of adenine and cytosine base editors for precision point mutation correction in inherited genetic disorders.

Tumor Immune Microenvironment Profiling

Integrated genomic and spatial analysis of immune cell infiltration and activation patterns within tumors to predict immunotherapy response.

Rare Disease Gene Discovery Pipeline

Development of systematic workflows combining exome sequencing, functional validation, and clinical assessment for undiagnosed monogenic disease gene identification.

Cancer Driver Gene Prioritization

Computational integration of genomic, functional, and pathway-based evidence to distinguish true cancer drivers from passenger mutations.

Spatial Transcriptomics Tissue Architecture

Integration of transcriptomic data with spatial information to map cellular heterogeneity and microenvironment signatures within tissue sections.

Gene Expression Signature Validation

Clinical translation and prospective validation of transcriptomic biomarkers for prognosis prediction and treatment response stratification.

Chromatin Accessibility Disease Association

ATAC-seq and DNase-seq based identification of disease-associated regulatory elements for mechanistic understanding and therapeutic targeting.

Haplotype-Aware Variant Interpretation

Integration of haplotype context and linkage disequilibrium patterns to improve accuracy of variant functional prediction and disease association studies.

Protein-Altering Variant Functional Assay

High-throughput experimental characterization of missense mutations to assess protein function, stability, and disease pathogenicity.

Recurrent Cancer Genomic Evolution

Serial genomic profiling and clonal analysis of recurrent tumors to understand acquired resistance mechanisms and inform sequential therapy strategies.

Disease Gene Network Pathway Analysis

Systems biology integration of disease genes into molecular networks to identify shared pathways and discover novel therapeutic intervention points.

Multi-Region Tumor Heterogeneity Analysis

Spatial and temporal genomic characterization of intra-tumor clonal architecture to elucidate tumor evolution and treatment resistance patterns.

Germline Cancer Predisposition Genes

Discovery and clinical implementation of hereditary cancer syndrome genes for risk stratification and surveillance strategy optimization.

RNA Binding Protein Target Mapping

CLIP-seq and iCLIP-based identification of RNA binding protein targets to understand gene expression dysregulation in disease contexts.

Allele-Specific Expression Imbalance

Quantification of cis-acting regulatory variant effects on monoallelic expression patterns as mechanistic biomarkers for disease association.

Precision Medicine Clinical Trial Design

Development of adaptive trial frameworks incorporating genomic biomarkers for improved efficacy, safety assessment, and patient stratification.

Transposable Element Activation Disease

Investigation of aberrant transposable element mobilization in cancer and genetic diseases through transcriptomic and genomic approaches.

Copy Number Variation Cancer Biology

Functional characterization of recurrent copy number alterations in tumors to identify dosage-sensitive cancer genes and driver mechanisms.

Disease Subtype Molecular Classification

Transcriptomic and genomic profiling-based stratification of complex diseases into biologically distinct subtypes for targeted treatment approaches.

Genome-Wide Association Study Replication

Functional validation and clinical translation of GWAS-identified variants to establish causality and develop risk prediction tools.

Targeted RNA Degradation Therapeutics

Development of PROTAC-based and targeted degradation technologies for therapeutic silencing of disease-causing or aberrantly expressed transcripts.

Environmental Gene Interaction Exposure

Integration of genomic and environmental exposure data to understand gene-by-environment interactions in disease susceptibility and outcomes.

Organoid Model Genomic Validation

Genomic profiling of patient-derived organoids to validate genetic findings and model drug response in three-dimensional tissue contexts.

Circular RNA Disease Biomarkers

Discovery and clinical validation of circRNA expression signatures as stable blood-based biomarkers for disease diagnosis and monitoring.

Metabolic Genomics Disease Phenotype

Integration of genomic variants with metabolic pathway analysis to identify metabolic drivers of disease and guide intervention strategies.

Machine Learning Variant Pathogenicity Scoring

Development of ensemble machine learning models integrating genomic, structural, and functional features for variant pathogenicity prediction.

Therapeutic Gene Editing Efficacy Assessment

Clinical and preclinical methodologies for measuring on-target editing efficiency, off-target modification, and therapeutic benefit of gene editing interventions.

Enhancer RNA Therapeutic Target Discovery

Investigation of enhancer RNAs as regulatory molecules for disease intervention and development of targeting strategies in translational settings.

Prime Editing Clinical Translation Optimization

Development and optimization of prime editing technologies for precise genomic corrections with improved safety profiles for therapeutic application.

Extracellular Vesicle RNA Cargo Therapeutics

Engineering and delivery of therapeutic RNA payloads using natural extracellular vesicles for organ-specific disease treatment.

Intra-Tumor Genetic Heterogeneity Mapping

Comprehensive characterization of spatial and clonal genetic diversity within tumors to predict therapeutic resistance and progression.

Antisense Oligonucleotide Clinical Efficacy Prediction

Development of computational models predicting therapeutic outcomes of antisense molecules targeting disease-associated RNA transcripts.

Germline Mosaicism Risk Stratification Frameworks

Establishment of diagnostic and prognostic frameworks for identifying germline mosaic variants in hereditary disease families.

Long-Range Chromosomal Interaction Disease Modeling

Investigation of three-dimensional genome topology alterations in disease pathogenesis using Hi-C and chromosome conformation capture technologies.

Intron-Retained Transcript Functional Characterization

Systematic analysis of intron retention events as regulatory mechanisms and disease biomarkers in cancer and neurological disorders.

Protein Truncation Variant Nonsense-Mediated Decay

Investigation of nonsense-mediated decay escape mechanisms and therapeutic targeting to modulate expression of truncated disease proteins.

Genomic Risk Prediction Machine Learning Models

Development of integrated machine learning architectures combining genomic and clinical data for polygenic disease risk prediction.

Metabolite-Modified DNA Lesion Detection

Characterization of metabolic byproduct-induced DNA modifications and their role in mutagenesis and disease initiation.

Therapeutic Gene Silencing Off-Target Prediction

Development of algorithms and experimental validation methods for predicting unintended transcriptome effects of RNA interference therapeutics.

Promoter Mutation Disease Association Analysis

Large-scale investigation of regulatory sequence mutations affecting gene expression levels and causing complex genetic diseases.

Patient Stratification Multi-Omics Biomarkers

Integration of genomic, transcriptomic, and proteomic data for precision patient classification and treatment selection.

X-Linked Disease Dosage Compensation Modeling

Investigation of X-inactivation patterns and their consequences in X-linked disease manifestation and therapeutic targeting.

Therapeutic siRNA Delivery Organ Targeting

Engineering of ligand-conjugated siRNA delivery systems for tissue-specific silencing of disease-associated genes.

Tumor Mutational Burden Immunotherapy Response

Correlation of somatic mutation load with immune checkpoint inhibitor efficacy and development of TMB-based patient selection strategies.

De Novo Mutation Disease Phenotype Correlation

Systematic characterization of spontaneous germline variants and their functional consequences in developmental and neuropsychiatric disorders.

Epigenetic Memory Reprogramming Disease Reversal

Investigation of therapeutic strategies to reset aberrant epigenetic landscapes underlying age-related and degenerative diseases.

Alternative Polyadenylation Disease Mechanism

Functional analysis of 3-prime untranslated region variants affecting transcript stability and disease pathogenesis.

Single-Nucleotide Polymorphism Functional Annotation

High-throughput functional validation of non-coding SNPs to establish mechanistic links to disease susceptibility.

Immunoglobulin Receptor Clonality Disease Progression

Sequencing-based analysis of antibody repertoire clonal dynamics as prognostic indicator in lymphoproliferative disorders.

MicroRNA Seed Region Target Specificity

Mechanistic characterization of miRNA-mRNA interactions and development of seed-matched therapeutic miRNA inhibitors.

Cryptic Exon Activation Cancer Evolution

Discovery and functional characterization of aberrantly included exons driving oncogenic isoform production in tumors.

Quantitative Trait Nucleotide Fine-Mapping

Integration of genome-wide association studies with functional genomics to identify causal variants in expression QTL.

Oncogenic Fusion Gene Transcript Validation

Comprehensive characterization of cancer-associated fusion transcripts and their therapeutic targeting opportunities.

Repair Gene Deficiency Mutation Signature

Development of mutational pattern recognition algorithms for identifying inherited DNA repair deficiencies affecting cancer predisposition.

Phenotype-Genotype Association Network Construction

Building comprehensive biological networks linking genomic variants to disease phenotypes for systems-level therapeutic discovery.

MitoNuclear Interaction Disease Pathophysiology

Investigation of incompatibility between nuclear and mitochondrial genetic backgrounds in metabolic and neurodegenerative diseases.

Therapeutic Antibody Somatic Mutation Engineering

Rational design of antibody variants using engineered somatic hypermutation pathways for enhanced therapeutic efficacy.

Non-Allelic Homologous Recombination Disease Risk

Mechanistic analysis of recurrent structural variants arising from NAHR mechanisms in disease-prone genomic regions.

Patient-Specific Induced Pluripotent Stem Cell Disease Modeling

Derivation and genomic characterization of patient iPSCs for disease mechanism investigation and drug response prediction.

Mutational Clock Development Chronological Analysis

Establishment of mutation accumulation rates as biological clocks for estimating developmental timing and disease progression.

Therapeutic Target Druggability Assessment Framework

Development of computational and experimental platforms predicting protein tractability for small molecule and biological therapeutic intervention.

Loss-of-Function Allele Penetrance Modifiers

Identification and characterization of genetic modifiers influencing clinical manifestation of pathogenic loss-of-function variants.

Glycan-Modified Therapeutic Protein Optimization

Engineering of protein glycosylation patterns for improved pharmacokinetics and therapeutic efficacy of recombinant gene products.

Chromatin Remodeling Complex Disease Association

Investigation of mutations in chromatin remodeling machinery as drivers of developmental and cancer-related genomic instability.

Competing Endogenous RNA Network Dysregulation

Mapping of ceRNA networks altered in disease states and therapeutic targeting of network hubs for disease modification.

Transcriptional Memory Cell Reprogramming Therapy

Development of therapeutic strategies to reverse aberrant transcriptional memory states underlying chronic inflammatory and autoimmune conditions.

Mosaic Cancer Driver Mutation Detection

Development of sensitive sequencing methods for identifying sub-clonal driver mutations in early cancer detection and monitoring.

Codon Usage Bias Therapeutic Optimization

Rational design of synthetic genes with optimized codon composition for improved translation efficiency of therapeutic proteins.

Methylation Quantitative Trait Locus Mapping

Genome-wide discovery of genetic variants influencing DNA methylation patterns and association with disease susceptibility.

Therapeutic Protein Aggregation Prevention Design

Structure-based engineering of recombinant therapeutic proteins for enhanced stability and reduced aggregation propensity.

Cancer Subclone Evolutionary Trajectory Prediction

Computational modeling of cancer clonal evolution from genomic snapshots to predict treatment resistance emergence.

Translation Efficiency Disease-Causing Mutation

Investigation of synonymous and regulatory mutations affecting translation rate and protein folding in genetic disease.

Genomic Instability Checkpoint Activation Therapy

Therapeutic targeting of sensing mechanisms to exploit synthetic lethality in genomically unstable malignancies.

Sex-Biased Disease Gene Expression Analysis

Systems-level investigation of sex chromosome and hormone-dependent expression alterations in sexually dimorphic genetic diseases.

Therapeutic CRISPR Array Multiplexed Editing

Development of polycistronic CRISPR systems for simultaneous correction of multiple disease-associated genomic defects.

Bioaccumulation Genetic Toxin Sensitivity

Investigation of genetic polymorphisms determining individual susceptibility to environmental and chemical mutagenic exposures.

Disease Remission Genomic Biomarker Discovery

Identification of genomic signatures and expression profiles predictive of sustained disease remission and treatment discontinuation.

Splicing Modulation Small Molecule Compounds

Development and translation of small-molecule therapeutics that modulate pre-mRNA splicing patterns to restore protein function in genetic diseases.

Xenograft Tumor Evolution Clonal Dynamics

Investigation of temporal clonal architecture and evolutionary trajectories in patient-derived xenograft models using multi-timepoint genomic profiling.

Antisense Oligonucleotide Exon Skipping

Design and clinical optimization of antisense therapies targeting specific exons for treating frameshift mutations in neuromuscular disorders.

Mitochondrial Heteroplasmy Load Stratification

Quantification and prognostic assessment of heteroplasmic mitochondrial DNA mutations across tissues for disease severity prediction.

Telomere Biology Cancer Stem Cell

Examination of telomerase activity and telomere maintenance mechanisms in cancer stem cell populations and therapeutic implications.

Ultra-Deep Sequencing Minimal Residual Disease

Application of error-corrected deep sequencing platforms to detect circulating disease DNA at parts-per-million sensitivity for cancer monitoring.

Chromatin Remodeling Complex Dysfunction

Functional characterization of mutations in SWI/SNF and other chromatin remodeling complexes driving malignant transformation.

Long Non-Coding RNA Regulation Disease

Mechanistic analysis of dysregulated lncRNA expression and their role as therapeutic targets in cardiovascular and neurological diseases.

Prime Editing Precision Therapeutic Development

Engineering and translation of prime editing systems for precise DNA modifications without double-strand breaks in patient cells.

Immunopeptidome HLA Ligandome Analysis

Comprehensive mapping of MHC-presented peptide repertoires to identify immunogenic epitopes for cancer vaccine and immunotherapy design.

Disease Associated Regulatory Element Discovery

Systematic identification and functional validation of disease-causing mutations in enhancers and silencers through ATAC and reporter assays.

RNA Secondary Structure Disease Pathogenesis

Investigation of RNA misfolding and aberrant secondary structures as mechanisms of toxicity in nucleotide repeat expansion disorders.

Protein Truncation Nonsense Suppression Therapy

Development of readthrough-inducing agents and genetic suppression strategies for treating nonsense mutation-induced protein-truncating diseases.

Mosaic Somatic Mutation Age-Related Risk

Characterization of clonal hematopoiesis and tissue-specific mosaic mutations as predictors of age-related disease and malignancy risk.

Variant Effect Prediction Machine Learning

Development of deep learning models integrating protein structure, conservation, and cellular context for predicting variant functional consequences.

Gene Dosage Imbalance Neurological Disease

Analysis of copy number variations affecting genes in dosage-sensitive pathways implicated in neurodevelopmental disorders and autism spectrum conditions.

Intercellular Transfer Extracellular Vesicles

Investigation of horizontal nucleic acid transfer through exosomes and microvesicles in tumor cell communication and metastatic disease.

Epistatic Interaction Disease Phenotype Prediction

Mapping and functional validation of high-order genetic interactions that modulate disease expressivity and therapeutic response.

Hematopoietic Progenitor Clonal Evolution

Single-cell genomic tracking of hematopoietic stem cell clones and their expansion patterns during aging and malignant transformation.

Tissue-Specific Enhancer Distal Regulation

Identification of tissue-restricted enhancer elements and their three-dimensional interactions governing context-dependent disease gene expression.

Protein Aggregation PolyQ Disease Mechanism

Elucidation of polyglutamine expansion toxicity through aggregation kinetics and targeted proteostasis network interventions.

Mutational Signature Carcinogen Exposure History

Deconvolution of tumor mutational signatures to reconstruct carcinogen exposure timelines and predict therapeutic vulnerability.

Regulatory SNP Allelic Imbalance Disease

Functional characterization of disease-associated regulatory variants causing preferential allelic expression and disease manifestation.

Metastatic Niche Organotropic Adaptation Genomics

Investigation of organ-specific genomic and transcriptomic adaptations enabling metastatic cancer cells to establish growth in distant sites.

Inactivated X Chromosome Skewing Disease

Analysis of non-random X-inactivation patterns as genetic modifiers in female carriers of X-linked disease mutations.

Homologous Recombination Deficiency Biomarker

Development of genomic assays measuring homologous recombination capacity to predict PARP inhibitor sensitivity in cancer treatment.

Loss Heterozygosity Tumor Suppressor Pathway

Characterization of clonal patterns of allelic loss affecting tumor suppressor genes and implications for therapeutic targeting.

Adaptive Immune Receptor Clonality Monitoring

High-throughput sequencing of T-cell and B-cell receptor repertoires to track clonal evolution in hematologic malignancies.

Retroviral Integration Site Mutagenesis Risk

Genome-wide mapping of integration hotspots and associated mutagenic outcomes for gene therapy safety assessment.

Viral Genome Mutation Rate Evolution Host

Investigation of viral genomic evolution and host-pathogen interactions influencing therapeutic resistance and vaccine efficacy.

DNA Damage Response Fidelity Cancer

Characterization of defective DNA repair pathway activation and its role in genomic instability driving malignant progression.

Therapeutic Antisense RNA Kidney Disease

Translation of antisense oligonucleotide therapeutics targeting glomerulonephritis-associated genes and renal fibrosis pathways.

Single Nucleotide Polymorphism Ancestry Inference

Application of ancestry-informative markers to correct for population structure in genomic studies and personalize risk estimates.

Prion Protein Conformational Disease Biomarker

Genomic and proteomic analysis of prion disease susceptibility variants and prion strain-specific diagnostic biomarkers.

Triplet Repeat Expansion Instability Mechanism

Mechanistic investigation of trinucleotide repeat expansion dynamics and cis/trans factors governing intergenerational instability.

Transcriptional Memory Epigenetic Inheritance Pattern

Characterization of heritable epigenetic modifications and their contribution to environmentally-induced disease phenotypes.

Metabolite Mediated Epigenetic Dysregulation

Investigation of altered metabolite production affecting histone and DNA modifications in metabolic disorder pathogenesis.

Biofilm Associated Microbial Genomic Signature

Metagenomic profiling of biofilm-forming microbial communities and antimicrobial resistance gene enrichment in chronic infections.

Off-Target CRISPR Indel Prediction Model

Machine learning integration of thermodynamics and chromatin accessibility to predict CRISPR guide RNA off-target effects genome-wide.

Germline Mosaicism Recurrence Risk Assessment

Deep sequencing and computational methods to detect and quantify germline mosaicism affecting genetic counseling recommendations.

Phenotype-Genotype Correlation Machine Learning

Development of integrative computational frameworks linking clinical phenotypes to genomic profiles for disease mechanism discovery.

Tumor Endothelial Cell Genomic Interaction

Investigation of genetic aberrations in tumor-associated vasculature and angiogenic dependencies for therapeutic targeting.

Fibroblast Growth Factor Pathway Alteration

Comprehensive genomic analysis of FGF pathway dysregulation through mutations, fusions, and copy number changes in cancer.

Intrinsic Subtype Tumor Classification Model

Refinement of molecular tumor classification schemes using multi-omics integration for treatment selection and prognosis.

Neural Crest Migration Developmental Genomics

Investigation of genetic variants disrupting neural crest specification and migration in congenital syndrome pathogenesis.

Therapeutic Protein Production Optimization Engineering

Genomic engineering of expression systems to enhance recombinant protein yield and biophysical properties for therapeutic development.

Age-Related Clonal Hematopoiesis Risk Stratification

Prognostic assessment of driver mutations in clonal hematopoiesis for predicting cardiovascular and hematologic disease outcomes.

Post-Transcriptional Regulation Circular RNA Network

Elucidation of circular RNA-microRNA-mRNA networks governing post-transcriptional gene expression in disease states.

Structural Genomic Variant Phenotype Association

Large-scale mapping of structural variations to clinical phenotypes using long-read sequencing and three-dimensional genomic analysis.

Enhancer RNA Regulatory Network Mapping

Investigating the functional roles of enhancer RNAs in gene regulation and their therapeutic targeting potential in disease contexts.

Whole Genome Duplication Cancer Evolution

Analyzing polyploid cancer cell populations and their genomic consequences for treatment resistance and disease progression.

Transcription Factor Binding Site Prediction

Developing machine learning models to predict and validate transcription factor binding across diverse genomic contexts and cell types.

Liquid-Liquid Phase Separation Genomics

Exploring genomic mechanisms underlying biomolecular condensates and their dysregulation in neurological and cancer diseases.

Telomere Dysfunction Disease Mechanism

Characterizing telomere biology alterations and their genomic consequences in aging and age-related pathologies.

Alternative Polyadenylation Clinical Significance

Identifying dysregulated polyadenylation patterns as biomarkers and therapeutic targets in human disease.

Trans-Acting Regulatory Element Discovery

Uncovering long-range genomic interactions and trans factors that govern disease-associated gene expression dysregulation.

GWAS Fine-Mapping Causal Variant Resolution

Employing functional genomics to identify causal variants underlying genome-wide association study signals in complex diseases.

Tumor Microenvironment Cell-Cell Communication

Mapping intercellular signaling networks between malignant and stromal cells using spatially-resolved genomic methods.

Precision Dosage Compensation X-Linked Disorders

Investigating X-inactivation patterns and dosage compensation mechanisms in X-linked disease pathogenesis and treatment.

Spacer Acquisition CRISPR System Engineering

Optimizing CRISPR spacer design and acquisition strategies for improved targeting specificity in therapeutic applications.

Mosaic Somatic Mutation Brain Development

Characterizing clonal and subclonal somatic mutations in neuronal populations and their neurodevelopmental disease associations.

Immunoglobulin V Region Diversity Engineering

Designing therapeutic antibodies through rational immunoglobulin genomic engineering and synthetic antibody library generation.

Patient Stratification Immunotherapy Response

Developing genomic biomarkers to predict immunotherapy efficacy and guide personalized cancer immunotherapy selection.

Retrotransposon-Driven Oncogenic Fusion Gene

Identifying and characterizing somatic retrotransposon insertions that generate cancer-associated fusion transcripts and neoantigens.

Bacterial Artificial Chromosome Therapeutic Delivery

Engineering large genomic DNA constructs using BAC technology for delivery of multi-gene therapeutic payloads.

DNA Damage Response Gene Mutation Signature

Profiling DNA repair pathway mutations as predictive biomarkers for precision oncology treatment selection.

Intergenic Region Conservation Clinical Prediction

Leveraging phylogenetic conservation of non-coding regions to predict pathogenic variant effects in human disease.

Single-Molecule Long-Read Haplotyping

Resolving compound heterozygous variants and cis-regulatory epistasis using ultra-long read sequencing technologies.

Mutational Signature Cancer Type Classification

Applying mutational signatures and trinucleotide patterns for cancer subtype identification and treatment prediction.

Glycan Gene Expression Disease Phenotype

Characterizing glycosylation pathway genomics and glycoprotein modifications in immunological and neurological diseases.

Epigenetic Drug Response Prediction Algorithm

Integrating chromatin state and epigenetic data to predict chemotherapy and targeted therapy drug responses.

Pseudogene Expression Functional Characterization

Elucidating the regulatory and functional roles of pseudogene transcripts in human disease context.

Aneuploidy Tolerance Cancer Cell Fitness

Investigating chromosomal instability burden and aneuploidy-induced gene dosage imbalance in cancer progression.

Codon Optimized Gene Synthesis Translation

Designing optimized coding sequences for enhanced expression in therapeutic gene delivery and protein replacement therapy.

Spatial Multi-Omics Tissue Heterogeneity

Integrating genomic, transcriptomic, and proteomic data with spatial information to map tissue-level disease mechanisms.

Mutation Timing Clonal Evolution Inference

Inferring acquisition order of somatic mutations to reconstruct tumor evolutionary history and metastatic trajectory.

Vertical Gene Transfer Pathogen Genomics

Studying pathogenic microorganism genomic evolution through vertical gene transfer and adaptive mutations.

Centromere Repeat Variation Human Disease

Characterizing complex centromeric repeat structures and their instability in chromosomal disorders and cancers.

Adaptive Immune Clonotype Expansion Kinetics

Tracking T cell and B cell clonotype dynamics during infection and immunotherapy using high-throughput sequencing.

Secreted Protein Signal Peptide Engineering

Optimizing signal peptide sequences for improved recombinant therapeutic protein secretion and bioavailability.

Heterochromatin Spreading Epigenetic Disease

Investigating heterochromatin propagation mechanisms and their role in progressive epigenetic silencing diseases.

Immunogenicity Prediction Personalized Vaccine

Designing patient-specific neoantigen vaccine content using germline and somatic mutation integration.

Cryptic Splice Site Activation Disease

Identifying disease-causing variants that activate cryptic splice sites and alter protein isoform composition.

Transcriptional Memory Chromatin Landscape

Mapping epigenetic memory states and poised chromatin domains that govern cell fate transitions in development.

Prion-Like Protein Aggregation Spreading

Investigating genomic factors controlling prion-like propagation of misfolded proteins in neurodegeneration.

Frameshift Mutation Compensatory Mechanism

Characterizing cellular mechanisms that tolerate or suppress frameshift mutation phenotypes in genetic diseases.

Xenobiotic Metabolism Gene Polymorphism

Mapping genetic variation in drug-metabolizing enzymes for predictive pharmacogenomics and toxicity prevention.

RNA Secondary Structure Disease Variant

Determining how disease variants alter RNA secondary structure to disrupt regulatory function and splicing.

Oncogene Addiction Dependency Map Construction

Building cancer cell dependency maps using CRISPR screens to identify precision oncology therapeutic targets.

Immunological Memory Germline Segment Selection

Analyzing V-D-J gene segment selection bias in memory B and T cells following vaccination or infection.

DNA Methylation Haplotype Block Association

Mapping methylation quantitative trait loci across haplotype blocks to identify trans-regulatory disease variants.

Therapeutic Antibody Humanization Algorithm

Developing computational methods for humanizing murine antibodies while preserving antigen binding affinity.

Metabolite Bioaccumulation Disease Progression

Characterizing metabolomic changes in genetic metabolic disorders and their genomic determinants of severity.

MHC Peptide Binding Affinity Prediction

Developing neural network models to predict HLA-peptide binding for personalized neoantigen vaccine design.

Silencer Element Activity Prediction Model

Creating machine learning models to identify and functionally predict transcriptional silencer elements in regulatory regions.

Carcinogen Exposure Mutation Signature Mapping

Linking environmental carcinogen exposures to specific mutational signatures for cancer origin attribution.

Synthetic Lethal Interaction Cancer Treatment

Discovering synthetic lethal gene pairs through functional genomics screens for precision cancer therapy development.

Enhancer RNA Disease Regulatory Element

Investigation of enhancer-derived RNA molecules as functional regulators in disease pathogenesis and their therapeutic targeting potential in precision medicine applications.

Pioneer Transcription Factor Accessibility

Characterizing pioneer factors that remodel chromatin accessibility and activate developmental enhancers in cell reprogramming.

Polygenic Architecture Cross-Population Risk Transferability

Development of methods to improve the accuracy and clinical utility of genomic risk prediction models across genetically diverse populations and ethnic backgrounds.